395 related articles for article (PubMed ID: 20220841)
1. Immunology and the elusive AIDS vaccine.
Virgin HW; Walker BD
Nature; 2010 Mar; 464(7286):224-31. PubMed ID: 20220841
[TBL] [Abstract][Full Text] [Related]
2. Toward an understanding of the correlates of protective immunity to HIV infection.
Haynes BF; Pantaleo G; Fauci AS
Science; 1996 Jan; 271(5247):324-8. PubMed ID: 8553066
[TBL] [Abstract][Full Text] [Related]
3. Immunology in AIDS in 1990.
Sela M
AIDS; 1990; 4 Suppl 1():S9-14. PubMed ID: 1983804
[No Abstract] [Full Text] [Related]
4. [Analytic and integrative perspectives for HIV vaccine design].
Yamamoto H
Uirusu; 2013; 63(2):219-32. PubMed ID: 25366056
[TBL] [Abstract][Full Text] [Related]
5. Immunology of infection with the human immunodeficiency virus.
Seligmann M
Recenti Prog Med; 1988; 79(7-8):330-7. PubMed ID: 2904683
[No Abstract] [Full Text] [Related]
6. HIV/AIDS vaccines: 2007.
Robinson HL
Clin Pharmacol Ther; 2007 Dec; 82(6):686-93. PubMed ID: 17971817
[TBL] [Abstract][Full Text] [Related]
7. Animal models for the study of human immunodeficiency virus infections.
Letvin NL
Curr Opin Immunol; 1992 Aug; 4(4):481-5. PubMed ID: 1356349
[TBL] [Abstract][Full Text] [Related]
8. AIDS vaccines: back to 'plan A'.
Check E
Nature; 2003 Jun; 423(6943):912-4. PubMed ID: 12827164
[No Abstract] [Full Text] [Related]
9. Sequential immunization of macaques with two differentially attenuated vaccines induced long-term virus-specific immune responses and conferred protection against AIDS caused by heterologous simian human immunodeficiency Virus (SHIV(89.6)P).
Kumar A; Lifson JD; Li Z; Jia F; Mukherjee S; Adany I; Liu Z; Piatak M; Sheffer D; McClure HM; Narayan O
Virology; 2001 Jan; 279(1):241-56. PubMed ID: 11145906
[TBL] [Abstract][Full Text] [Related]
10. Prospects for an AIDS vaccine: three big questions, no easy answers.
Garber DA; Silvestri G; Feinberg MB
Lancet Infect Dis; 2004 Jul; 4(7):397-413. PubMed ID: 15219551
[TBL] [Abstract][Full Text] [Related]
11. The quest for an AIDS vaccine: is the CD8+ T-cell approach feasible?
McMichael A; Hanke T
Nat Rev Immunol; 2002 Apr; 2(4):283-91. PubMed ID: 12001999
[TBL] [Abstract][Full Text] [Related]
12. Antigen presentation and related immunological aspects of HIV-1 vaccines.
Steinman RM; Germain RN
AIDS; 1998; 12 Suppl A():S97-112. PubMed ID: 9632991
[No Abstract] [Full Text] [Related]
13. Understanding the mechanisms and limitations of immune control of HIV.
Davenport MP; Ribeiro RM; Zhang L; Wilson DP; Perelson AS
Immunol Rev; 2007 Apr; 216():164-75. PubMed ID: 17367342
[TBL] [Abstract][Full Text] [Related]
14. Mucosal immune dysfunction in AIDS pathogenesis.
Paiardini M; Frank I; Pandrea I; Apetrei C; Silvestri G
AIDS Rev; 2008; 10(1):36-46. PubMed ID: 18385779
[TBL] [Abstract][Full Text] [Related]
15. AIDS vaccine development.
Lévy JP
Science; 1998 May; 280(5365):806-7. PubMed ID: 9599149
[No Abstract] [Full Text] [Related]
16. Why can't the immune system control HIV-1? Defining HIV-1-specific CD4+ T cell immunity in order to develop strategies to enhance viral immunity.
Ostrowski MA; Yu Q; Yue FY; Liu J; Jones B; Gu XX; Loutfy M; Kovacs CM; Halpenny R
Immunol Res; 2006; 35(1-2):89-102. PubMed ID: 17003512
[TBL] [Abstract][Full Text] [Related]
17. Development of prophylactic AIDS vaccines: the current state of affairs.
Hanke T
Curr Opin Mol Ther; 2003 Feb; 5(1):25-32. PubMed ID: 12669467
[TBL] [Abstract][Full Text] [Related]
18. Toward an AIDS vaccine.
Walker BD; Burton DR
Science; 2008 May; 320(5877):760-4. PubMed ID: 18467582
[TBL] [Abstract][Full Text] [Related]
19. Challenges in the search for an HIV vaccine.
Lemckert AA; Goudsmit J; Barouch DH
Eur J Epidemiol; 2004; 19(6):513-6. PubMed ID: 15330122
[TBL] [Abstract][Full Text] [Related]
20. Changing paradigms for an HIV vaccine.
Schultz AM
Adv Exp Med Biol; 1996; 397():79-90. PubMed ID: 8718586
[No Abstract] [Full Text] [Related]
[Next] [New Search]